鲁抗医药(600789.SH)：前三季度净利润1.41亿元，同比下降59.32%

Core Insights - Lu Kang Pharmaceutical (600789.SH) reported a total operating revenue of 4.624 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 0.91% [1] - The net profit attributable to shareholders of the parent company was 141 million yuan, down 59.32% year-on-year [1] - The basic earnings per share stood at 0.16 yuan [1]